Despite the evidence from human post-mortem studies showing an early disruption of VAPB-PTPIP51 binding, a number of other studies report an up-regulation of ER-mitochondria signaling functions in Alzheimer’s disease. Here, RMDN3 is linked to early-onset autosomal dominant Alzheimer disease.